Latest Board Composition News

Structural Monitoring Systems Plc reported a 55% jump in quarterly free cash flow to $1.4 million and eliminated its bank debt by repaying a C$0.8 million term loan. The company also launched the MTP138 radio targeting offshore markets and secured key certifications for its avionics products.

Yancoal Australia posted a record 38.6 million tonnes of attributable saleable coal in 2025, up 5% on 2024, but net profit after tax plunged 64% to A$440 million amid softer coal prices. The miner maintained disciplined cost control and declared A$769 million in fully franked dividends.

DroneShield Limited has appointed Angus Bean as its new CEO and Hamish McLennan as Chairman, following the departures of Oleg Vornik and Peter James. The company also reported record cash receipts of $77 million in the first quarter of 2026, reflecting strong growth momentum.

ARC Funds Limited and AUSBIZ Group have mutually cancelled the previously announced assignment of convertible notes in Ausbiz TV, reflecting a strategic shift following changes in ARC’s board and shareholder base.

Humm Group has appointed CEO Angelo Demasi as Managing Director, reinforcing governance and leadership alignment amid ongoing transformation efforts.

Novatti Group Limited has reported a striking turnaround to a $3.8 million profit in the first half of 2026, despite a 42% drop in revenue. The fintech’s strategic divestments and reclassification of its AUDC investment signal a pivotal shift in its growth trajectory.

BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.

Metrics Real Estate Multi-Strategy Fund has reported a striking increase in half-year profit and distributions, underpinned by strong commercial real estate investments across debt and equity portfolios.

WAM Active Limited reported a record half-year profit with its investment portfolio soaring 31.4%, significantly outperforming benchmarks. The company also declared increased fully franked dividends and completed a $70.7 million capital raise, boosting assets under management beyond $151 million.

HITIQ Limited reported a $2.9 million loss for the half-year ending December 2025, while making significant strides in international market expansion and strategic partnerships. The company’s capital raising efforts aim to support its transition from technology validation to commercial execution.

Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.